These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4011956)

  • 21. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of vasopressin analog [d(CH2)1(5),Tyr(Me)2]AVP on learning and memory in rats chronically treated with ethanol.
    Car H; Borawska MH; Wiśniewski K
    Pol J Pharmacol; 1993; 45(5-6):503-12. PubMed ID: 8012473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine vasopressin prevents against Abeta(25-35)-induced impairment of spatial learning and memory in rats.
    Pan YF; Chen XR; Wu MN; Ma CG; Qi JS
    Horm Behav; 2010 Apr; 57(4-5):448-54. PubMed ID: 20138885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evidence for a dissociation of peripheral and central effects of vasopressin.
    Gaffori O; de Wied D
    Psychoneuroendocrinology; 1985; 10(4):439-44. PubMed ID: 4089084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of vasopressin analog: [d(CH2)(1)5,Tyr(Me)2,delta 3Pro7]AVP on learning and memory processes in rats with experimental amnesia.
    Car H; Borawska M; Wiśniewski K
    Pol J Pharmacol; 1993; 45(1):11-22. PubMed ID: 8401755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].
    LeBrun CJ; Rigter H; Martinez JL; Koob GF; Le Moal M; Bloom FE
    Life Sci; 1984 Oct; 35(14):1505-12. PubMed ID: 6482669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesis.
    Le Moal M; Dantzer R; Mormède P; Baduel A; Lebrun C; Ettenberg A; van der Kooy D; Wenger J; Deyo S; Koob GF
    Psychoneuroendocrinology; 1984; 9(4):319-41. PubMed ID: 6514931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of vasopressin, des-glycinamide vasopressin and amphetamine on a combined passive and active avoidance task.
    Sahgal A
    Psychopharmacology (Berl); 1986; 90(4):494-8. PubMed ID: 3101105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of ACTH4-10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats.
    Wan R; Diamant M; de Jong W; de Wied D
    Physiol Behav; 1992 Mar; 51(3):507-13. PubMed ID: 1326112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressin analog delays extinction of classically conditioned bradycardia.
    Hernández LL; Powell DA
    Peptides; 1983; 4(1):37-41. PubMed ID: 6866807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressin and memory. I. The vasopressin analogue AVP4-9 enhances working memory as well as reference memory in the radial arm maze.
    Dietrich A; Allen JD
    Behav Brain Res; 1997 Sep; 87(2):195-200. PubMed ID: 9331487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Improvement of the selective perception and learning with the analog of C-terminal fragment of vasopressin in rats].
    Ponomareva NS; Voskresenskaia OG; Kanenskiĭ AA; Golubovich VP; Ashmarin IP
    Ross Fiziol Zh Im I M Sechenova; 1998 Dec; 84(12):1363-9. PubMed ID: 10204182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arginine vasopressin 4-9 retards spatial alternation learning.
    McDaniel WF; Waters PE; Davall EJ
    Neuropeptides; 1989; 14(4):219-24. PubMed ID: 2622521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral effects of arginine8-vasopressin in the Hebb-Williams maze.
    Paban V; Soumireu-Mourat B; Alescio-Lautier B
    Behav Brain Res; 2003 Apr; 141(1):1-9. PubMed ID: 12672553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze.
    Mishima K; Tsukikawa H; Miura I; Inada K; Abe K; Matsumoto Y; Egashira N; Iwasaki K; Fujiwara M
    Neuropharmacology; 2003 Mar; 44(4):541-52. PubMed ID: 12646291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term facilitation of social recognition in rats by vasopressin related peptides: a structure-activity study.
    Popik P; Van Ree JM
    Life Sci; 1992; 50(8):567-72. PubMed ID: 1736027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AVP (4-8) improves concept learning in PFC-damaged but not hippocampal-damaged rats.
    Dietrich A; Taylor JT; Passmore CE
    Brain Res; 2001 Nov; 919(1):41-7. PubMed ID: 11689161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Participation of the genetic apparatus of the hippocampal and neocortical cells in the mechanisms of action of desglycine-arginine vasopressin on learning and memory processes in rats].
    Bikbulatova LS; Orlova NV; Deviatov SB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1987; 37(6):1075-80. PubMed ID: 2452528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-related influence of arginine-vasopressin on a passive avoidance behavior: effect of rearing conditions.
    Crine AF
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):379-84. PubMed ID: 6541358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopressin administration modulates anxiety-related behavior in rats.
    Appenrodt E; Schnabel R; Schwarzberg H
    Physiol Behav; 1998 Jun; 64(4):543-7. PubMed ID: 9761230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.